Follow
Jerome Yesavage
Jerome Yesavage
Professor of Psychiatry and Neurology (By Courtesy), Stanford University School of Medicine
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Development and validation of a geriatric depression screening scale: a preliminary report
JA Yesavage, TL Brink, TL Rose, O Lum, V Huang, M Adey, VO Leirer
Journal of psychiatric research 17 (1), 37-49, 1982
191191982
Geriatric Depression Scale (GDS): recent evidence and development of a shorter version
JI Sheikh, JA Yesavage
Clinical gerontology, 165-173, 2014
90422014
Geriatric depression scale
JA Yesavage
Psychopharmacol bull 24 (4), 709-711, 1988
4456*1988
Screening tests for geriatric depression
TL Brink, JA Yesavage, O Lum, PH Heersema, M Adey, TL Rose
Clinical gerontologist 1 (1), 37-43, 1982
22781982
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
S Ray, M Britschgi, C Herbert, Y Takeda-Uchimura, A Boxer, K Blennow, ...
Nature medicine 13 (11), 1359-1362, 2007
12752007
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans
Nature communications 7 (1), 11934, 2016
9792016
Caution regarding the use of pilot studies to guide power calculations for study proposals
HC Kraemer, J Mintz, A Noda, J Tinklenberg, JA Yesavage
Archives of general psychiatry 63 (5), 484-489, 2006
7542006
Context processing in older adults: evidence for a theory relating cognitive control to neurobiology in healthy aging.
TS Braver, DM Barch, BA Keys, CS Carter, JD Cohen, JA Kaye, ...
Journal of Experimental Psychology: General 130 (4), 746, 2001
6392001
How can we learn about developmental processes from cross-sectional studies, or can we?
HC Kraemer, JA Yesavage, JL Taylor, D Kupfer
American Journal of Psychiatry 157 (2), 163-171, 2000
5672000
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial
AP Porsteinsson, LT Drye, BG Pollock, DP Devanand, C Frangakis, ...
Jama 311 (7), 682-691, 2014
5592014
CSF hypocretin/orexin levels in narcolepsy and other neurological conditions
B Ripley, S Overeem, N Fujiki, S Nevsimalova, M Uchino, J Yesavage, ...
Neurology 57 (12), 2253-2258, 2001
4882001
Gender differences in moderate drinking effects
MS Mumenthaler, JL Taylor, R O’Hara, JA Yesavage
Alcohol Research & Health 23 (1), 55, 1999
4821999
The validation of the short form of the Geriatric Depression Scale (GDS) in Greece
KN Fountoulakis, M Tsolaki, A Iacovides, J Yesavage, R O’Hara, A Kazis, ...
Aging Clinical and Experimental Research 11, 367-372, 1999
4371999
Effects of phosphatidylserine in age‐associated memory impairment
TH Crook, J Tinklenberg, J Yesavage, W Petrie, MG Nunzi, DC Massari
Neurology 41 (5), 644-649, 1991
4191991
In vivo staging of regional amyloid deposition
MJ Grothe, H Barthel, J Sepulcre, M Dyrba, O Sabri, SJ Teipel, ...
Neurology 89 (20), 2031-2038, 2017
3762017
Proposed factor structure of the Geriatric Depression Scale
JI Sheikh, JA Yesavage, JO Brooks, L Friedman, P Gratzinger, RD Hill, ...
International psychogeriatrics 3 (1), 23-28, 1991
3711991
Variable effects of aging on frontal lobe contributions to memory
AC Rosen, MW Prull, R O'Hara, EA Race, JE Desmond, GH Glover, ...
Neuroreport 13 (18), 2425-2428, 2002
2922002
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 6760, 2015
2872015
Estrogen replacement therapy and memory in older women
D Robinson, L Friedman, R Marcus, J Tinklenberg, J Yesavage
Journal of the American Geriatrics Society 42 (9), 919-922, 1994
2861994
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
TW Schmitz, R Nathan Spreng
Nature communications 7 (1), 13249, 2016
2792016
The system can't perform the operation now. Try again later.
Articles 1–20